leadf
logo-loader
viewEmpower Clinics Inc.

Empower Clinics to triple the size of its KAI Medical Laboratory in Dallas

The expansion comes as the company anticipates more growth in COVID-19 test requirements in the US, Canada, and international markets

covid
The lab just exceeded 1,000 COVID-19 test units in a single day for the first time

Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) (FRA:8EC) announced Monday that its KAI Medical Laboratory in Dallas, Texas has exceeded 1,000 coronavirus (COVID-19) test units in a single day for the first time. 

As a result, Empower is announcing that KAI LAB will undergo an even larger expansion in anticipation of projected growth in COVID-19 test requirements in the US, Canada, and international markets. 

The company acquired the state-of-the-art diagnostics laboratory last October to further advance the company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses, and the travel industry. 

READ: Empower Clinics obtains MDEL status to sell KAI Medical coronavirus test kits in Canada

Empower said the lab experienced significant growth in its first-quarter under the company (October 2020 to December 2020), with COVID-19 test units exceeding 6,000 specimens processed, far surpassing the less than 1,000 total monthly units prior to acquisition.

As a result, Empower last month announced that it would be double testing volumes -- but is now revising again this planned expansion upwards by tripling its current size in anticipation of projected growth in COVID-19 test requirements.

"Today marks a significant milestone for Empower and our shareholders,” said Empower CEO Steven McAuley in a statement. 

“When we first acquired KAI Medical Laboratory just over four months ago, it was processing less than 1,000 specimens monthly up to that point. Today, we are announcing that KAI has surpassed 1,000 units in a day for the first time ever. This is a credit to both Yoshi Tyler, President KAI LAB and her fantastic team, supported by our business development and marketing strategies which, quite frankly, are still in an early phase. We are just getting started."

For the purposes of facilitating the expansion, Empower said it has secured additional space adjacent to KAI LAB to separate the lab & science from logistics, administration, and customer support. Materials-handling staff are being added in anticipation of processing the intake of thousands of packages per day.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Empower Clinics Inc.

Price: 1.24 CAD

CSE:CBDT
Market: CSE
Market Cap: $243.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Empower Clinics Inc. named herein, including the promotion by the Company of Empower Clinics Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Empower Clinic’s Kai Labs plans to increase capacity while confirming...

Empower Clinics (CSE: CBDT- OTCQB: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling from Proactive with news the company’s subsidiary Kai Labs has confirmed their PCR test products are able to accurately detect the UK and South African Variant. McAuley discusses the significance of...

1 week ago

2 min read